Medical Condition News

RSS

Soligenix commences enrollment in its Phase 3 Orbec clinical trial for acute GI GVHD

Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).

15 Oct 2009

Prometheus Laboratories introduces three new cancer diagnostic products

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the nationwide commercial launch of three new cancer diagnostic products: ProOnc TumorSource Dx, ProOnc Squamous Dx and ProOnc Mesothelioma Dx. Each of these tests is based on recently developed, highly sensitive microRNA technology.

15 Oct 2009

Breathe Right "Extra" to help consumers sleep better at night

While many of us will never know the feeling of playing in a professional football game, we all should know the feeling of getting a good night's sleep. However, many adults suffer from night-time congestion, a good night's sleep can be as elusive as a speedy running back - until now.

15 Oct 2009

Inspire to present its denufosol tetrasodium cystic fibrosis program data at the 23rd NACFC

Inspire Pharmaceuticals, Inc. announced today Inspire scientists and collaborators will present data from the denufosol tetrasodium cystic fibrosis (CF) program in a poster presentation at the 23rd Annual North American Cystic Fibrosis Conference (NACFC) October 15 - 17, 2009 in Minneapolis, MN.

15 Oct 2009

New range of foods from marine animals and plants to help fight human diseases

Milk drinks that lower blood pressure, meat products that reduce the risk of heart disease, chocolate that calms you down and a new range of foods that can fight obesity can be created from marine animals and plants. Japan already has several product ranges on the shelves and research programmes are underway all over the world to create more.

15 Oct 2009

Managing Myeloma launches educational activities for multidisciplinary professionals

Managing Myeloma (www.ManagingMyeloma.com), an accredited educational initiative for multidisciplinary professionals, announces the launch of a series of regional continuing education activities to be held through October and November in five western states.

15 Oct 2009

Sangretech Biomedical signs amended license agreement with Bostwick Laboratories

Sangretech Biomedical LLC, a developer of dendritic cell therapies for cancer and infectious diseases, today announced it has executed an amended and restated license agreement with Bostwick Laboratories, Inc. providing Bostwick Scientific, the research division of Bostwick Laboratories, with exclusive rights to Sangretech’s dendritic cell technology in certain territories.

15 Oct 2009

Managing Myeloma website offers scholarship for attending the December 2009 American Society of Hematology Annual Meeting

Managing Myeloma (www.ManagingMyeloma.com), an accredited multi-supported educational website for multidisciplinary professionals, announces the opportunity for fellows in oncology to win a scholarship to attend the December 2009 American Society of Hematology Annual Meeting in New Orleans, Louisiana. The scholarship includes registration fees, airfare, hotel accommodations, and a per diem for meals.

15 Oct 2009

Positive results from Protalix BioTherapeutics Phase III UPLYSO clinical trial

Protalix BioTherapeutics, Inc., announced today positive top-line results from the Company's pivotal Phase III clinical trial of UPLYSO (taliglucerase alfa, previously referred to as prGCD) in treatment naive patients diagnosed with Gaucher disease.

15 Oct 2009

ADI and CeTeCancer collaborate for research project

Radient Pharmaceuticals Corporation, a US-based pharmaceutical company, announced today it has entered into a collaboration agreement through its wholly owned subsidiary AMDL Diagnostics, Inc. (ADI) with CeTeCancer -- a Chilean-based research laboratory -- to validate the effectiveness of Radient Pharmaceuticals' Onko-Sure™ in vitro diagnostic (IVD) cancer test as an early detection and prevention test for lung cancer.

15 Oct 2009

EP Global Communications to co-produce World Congress & Exposition on Disabilities conference

Some companies just don't get the attention and recognition that other more popular corporations do. But it seems that may all be changing as a growing number of people are seeking companies which perform services that affect the greater good of society.

15 Oct 2009

Vegetable lamb plant: New treatment for osteoporosis

The "vegetable lamb" plant - once believed to bear fruit that ripened into a living baby sheep - produces substances that show promise in laboratory experiments as new treatments for osteoporosis, the bone-thinning disease. That's the conclusion of a new study in ACS' monthly Journal of Natural Products.

15 Oct 2009

Delays contribute to unnecessary ER visits and additional imaging services in symptomatic gallstone treatment

Getting patients to the operating room more quickly could cut by half the amount paid for hospital treatment of painful gallstones, researchers reported today at the 2009 Clinical Congress of the American College of Surgeons.

15 Oct 2009

A study on development of deaf children fitted with a Cochlear Implant

A multidisciplinary group at Malaga University, headed by Ignacio Moreno-Torres, is collecting information on the milestones that mark the development of deaf children fitted with a Cochlear Implant (CI) and studying to what extent the social and family environment affects this development. This research is funded with 101,000 euro by the Andalusian Regional Ministry of Innovation.

15 Oct 2009

Negative symptoms represent an attractive target for drug development

A half-day workshop on issues in the design of clinical trials to evaluate treatments for negative symptoms of schizophrenia, chaired by Stephen Marder, MD, UCLA Department of Psychiatry and David Daniel, M.D., United BioSource Corporation was held 5 October 2009, as part of the International Society for CNS Clinical Trials and Methodology (ISCTM) Autumn Conference in San Diego, CA.

15 Oct 2009

National Biological to market Quantel's 308 Excimer System in the U.S.

Quantel SA (Euronext: QUA), a leading manufacturer of solid state lasers, announced today that it has entered into a Distribution Agreement with National Biological, a leading researcher and developer of light-based systems for medical and cosmetic treatments, for Quantel's 308 Excimer System for monochromatic UVB treatment of psoriasis and vitiligo in the United States.

15 Oct 2009

Slavica BioChem scientists reverse multidrug resistance in lung cancer using small molecules

HTDS - The issuer's Serbia based operating subsidiary Slavica BioChem www.slavicabiochem.com brings attention to its Mindup Bioresearch cancer project working on molecular origins of lung cancer: prospects for personalized prevention and therapy. On October 8 2009, the company posted a filing on Pink Sheets titled MindUp Cancer Project.

15 Oct 2009

Specific immune system cells linked to susceptibility of younger people to variant CJD

Specific cells within the immune system could help explain why younger people are more susceptible to variant CJD, scientists believe.

15 Oct 2009

pSivida achieves milestone in Phase III Iluvien trial, last patient completes two-year follow up visit

pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that the last patient in the Phase III clinical trial being conducted by its collaborative partner, Alimera Sciences, for a new treatment for diabetic macular edema (DME) has completed the two-year follow up visit.

15 Oct 2009

Scientists are trying to decipher the chemistry of human odor

Each of the 6.7 billion people on Earth has a signature body odor - the chemical counterpart to fingerprints - and scientists are tracking down those odiferous arches, loops, and whorls in the "human odorprint" for purposes ranging from disease diagnosis to crime prevention. That's the topic of an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

15 Oct 2009

Medical Condition News

Soligenix commences enrollment in its Phase 3 Orbec clinical trial for acute GI GVHD

Prometheus Laboratories introduces three new cancer diagnostic products

Breathe Right "Extra" to help consumers sleep better at night

Inspire to present its denufosol tetrasodium cystic fibrosis program data at the 23rd NACFC

New range of foods from marine animals and plants to help fight human diseases

Managing Myeloma launches educational activities for multidisciplinary professionals

Sangretech Biomedical signs amended license agreement with Bostwick Laboratories

Managing Myeloma website offers scholarship for attending the December 2009 American Society of Hematology Annual Meeting

Positive results from Protalix BioTherapeutics Phase III UPLYSO clinical trial

ADI and CeTeCancer collaborate for research project

EP Global Communications to co-produce World Congress & Exposition on Disabilities conference

Vegetable lamb plant: New treatment for osteoporosis

Delays contribute to unnecessary ER visits and additional imaging services in symptomatic gallstone treatment

A study on development of deaf children fitted with a Cochlear Implant

Negative symptoms represent an attractive target for drug development

National Biological to market Quantel's 308 Excimer System in the U.S.

Slavica BioChem scientists reverse multidrug resistance in lung cancer using small molecules

Specific immune system cells linked to susceptibility of younger people to variant CJD

pSivida achieves milestone in Phase III Iluvien trial, last patient completes two-year follow up visit

Scientists are trying to decipher the chemistry of human odor

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News